Global Heart Pump Device Market

Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices (VADs), Intra-aortic balloon pumps (IABPs), Total artificial heart (TAH)), By Indication(Bridge-to-transplant (BTT), Destination therapy (DT), Bridge-to-recovery (BTR)), By End-user(Hospitals, cardiology centers, ambulatory surgical centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2376 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 90 |Figures: 76

Heart Pump Device Market Insights

Global Heart Pump Device Market size was valued at USD 2.09 billion in 2022 and is poised to grow from USD 2.61 billion in 2023 to USD 15.32 billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).

The global heart pump device market is experiencing significant growth globally. Our report contains detailed information on the value chain analysis for the Heart Pump Device market, which manufacturers can use to gain a competitive edge during the projected period. The primary driving factor for this market growth is the increasing prevalence of cardiovascular diseases worldwide.

With the rising incidence of heart failure, the demand for heart pump devices has surged as they play a critical role in supporting and maintaining heart function in patients with severe cardiac conditions. Moreover, the growing aging population, which is more prone to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward.

Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have significantly improved patient outcomes and have increased their adoption. The development of magnetically levitated ventricular assist devices (VADs), for instance, has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications.

The heart pump device market is the increasing adoption of mechanical circulatory support devices. As the prevalence of advanced heart failure cases continues to rise, the need for long-term mechanical support has become crucial. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients waiting for heart transplantation or those who are not suitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patients ineligible for transplant, has further expanded the market's reach.

US Heart Pump Device Market is poised to grow at sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 2.09 billion

Largest Segment

Ventricular Assist Devices (VADs)

Fastest Growth

Intra-Aortic Balloon Pumps (IABPs)

Growth Rate

24.77% CAGR

Global Heart Pump Device Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Heart Pump Device Market Segmental Analysis

The global Heart Pump Device market can be segmented based on product type, indication, end-user, and region. Based on product type, the market can be divided into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), total artificial heart (TAH). Based on indication, the market can be categorized into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR). Based on end-user, the market can be categorized into hospitals, cardiology centers, ambulatory surgical centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Heart Pump Device Market Analysis By Product Type

Ventricular Assist Devices (VADs) hold the largest share in the heart pump device market. VADs are further categorized into left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs) based on the ventricle they support. LVADs account for a significant portion of the VAD market due to their effectiveness in improving blood flow and prolonging survival in patients with end-stage heart failure. These devices are commonly used for both Bridge-to-Transplant (BTT) and Destination Therapy (DT) indications. The increasing adoption of LVADs in heart failure management has contributed to the dominance of the VAD segment in the market.

Intra-aortic balloon pumps (IABPs) represent the fastest growing segment in the heart pump device market. These devices provide temporary circulatory support by increasing coronary artery perfusion and reducing the workload of the heart. IABPs are widely used in high-risk procedures, such as cardiac surgeries and percutaneous coronary interventions (PCIs), as well as in patients with acute myocardial infarction and cardiogenic shock. These devices offer effective circulatory support during critical interventions, aiding in the stabilization of patients. Secondly, the demand for minimally invasive devices has surged, and IABPs fit this requirement as they can be inserted percutaneously.

Heart Pump Device Market Analysis By Indication

Destination Therapy (DT) is the largest segment in the heart pump device market by indication. DT involves the long-term use of heart pump devices as a permanent solution for patients who are not eligible for heart transplantation. This indication is primarily targeted at patients with end-stage heart failure who are not expected to recover heart function or receive a heart transplant. The DT segment has gained prominence due to several factors. The increasing prevalence of heart failure and the growing aging population contribute to the rising demand for long-term mechanical circulatory support.

The fastest-growing segment in the heart pump device market by indication is Bridge-to-Recovery (BTR). BTR refers to the temporary use of heart pump devices to support patients with acute heart failure, with the goal of allowing the heart to recover its normal function. This indication is gaining significant traction due to various factors. The growing recognition of the potential for cardiac recovery in certain patients has driven the demand for BTR. Heart pump devices provide mechanical support to the failing heart, allowing it to rest and heal, which may lead to a complete recovery and the removal of the device

Global Heart Pump Device Market By Product Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Heart Pump Device Market Regional Insights

North America holds the largest share in the heart pump device market. This can be attributed to several factors. Firstly, the region has a high prevalence of cardiovascular diseases, including heart failure, which drives the demand for heart pump devices. Additionally, North America has a well-established healthcare infrastructure and a high level of awareness about advanced medical technologies, contributing to the adoption of heart pump devices. The presence of key market players and ongoing research and development activities further support the growth of the market in this region.

On the other hand, the Asia Pacific region is the fastest-growing region in the heart pump device market. The market in this region is experiencing significant growth due to various factors. Firstly, there is a rising prevalence of cardiovascular diseases, primarily driven by lifestyle changes, an aging population, and an increase in risk factors such as obesity and diabetes. This has led to an increased demand for heart pump devices. Secondly, improving healthcare infrastructure and rising healthcare expenditure in countries like China, India, and Japan are facilitating the adoption of advanced medical technologies, including heart pump devices.

Global Heart Pump Device Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Heart Pump Device Market Dynamics

Heart Pump Device Market Drivers

Technological advancements

  • Continuous innovation and advancements in heart pump technology have significantly improved the performance and outcomes of these devices. Technological advancements have led to the development of smaller, more durable, and more efficient heart pump devices, resulting in enhanced patient comfort and improved quality of life. For example, the introduction of magnetically levitated ventricular assist devices (LVADs) has reduced device-related complications and improved patient outcomes.

Heart Pump Device Market Restraints

High Cost and Limited Reimbursement

  • Heart pump devices are sophisticated and complex medical technologies, making them expensive to manufacture and acquire. The high cost of heart pump devices poses a significant financial burden for patients, healthcare providers, and healthcare systems. Moreover, the limited reimbursement coverage for heart pump devices in some regions creates challenges for patients in accessing these life-saving technologies.

Request Free Customization of this report to help us to meet your business objectives.

Heart Pump Device Market Competitive Landscape

The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong global presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge.

Heart Pump Device Market Top Player’s Company Profile

  • Abbott Laboratories (US)
  • Medtronic PLC (Ireland)
  • LivaNova PLC (United Kingdom)
  • Berlin Heart GmbH (Germany)
  • SynCardia Systems, LLC (US)
  • Abiomed, Inc. (US)
  • Getinge AB (Sweden)
  • Terumo Corporation (Japan)
  • Teleflex Incorporated (US)
  • Jarvik Heart, Inc. (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Calon Cardio (United Kingdom)
  • CardiacAssist, Inc. (US)
  • BiVACOR Inc. (Australia)
  • Leviticus Cardio Ltd. (Israel)
  • CARMAT SA (France)
  • FineHeart SA (France)
  • MyLVAD (US)
  • MicroPort Scientific Corporation (China)
  • TandemLife, a LivaNova company (US)

Heart Pump Device Market Recent Developments

  • In February 2024, Monash University will lead a team to create innovative implantable cardiac devices aiming to provide long-term solutions for various types of heart failure. The Artificial Heart Frontiers Program, situated at the Monash Alfred Baker Centre for Cardiovascular Research at The Alfred, secured a $50 million grant from the Medical Research Future Fund (MRFF). The program intends to develop and bring to market three essential devices for treating prevalent forms of heart failure. The initiative, backed by Minister for Health and Aged Care, The Hon Mark Butler, seeks to revolutionize cardiac treatment, offering hope for patients with debilitating heart conditions.

  • In February 2024, the Artificial Heart Frontiers Program, led by BiVACOR in collaboration with several universities and healthcare institutions, secured the third-largest grant ever from the MRFF. This funding will support the development and commercialization of three key devices. Firstly, the Mini-Pump, a new miniature device implanted directly into the hearts of patients with no other treatment options for heart failure. Secondly, a novel left ventricle assist device (LVAD) placed next to the natural heart to aid pumping. Lastly, BiVACOR's Total Artificial Heart (TAH), which completely replaces the natural heart. These advancements aim to offer hope and improved treatment options for those with severe heart conditions.

  • In November 2023, the National Heart Centre Singapore (NHCS) collaborated with Medera’s Novoheart to develop the world's inaugural Asian patient-specific miniature human heart model afflicted with heart failure, named the "Human Heart-in-a-Jar".

Heart Pump Device Key Market Trends

  • Availability of compatible devices: Compatible devices are designed to work harmoniously with heart pump systems, optimizing their performance and ensuring efficient functioning. For example, advanced control units can provide precise management of pump flow and parameters, enhancing patient outcomes. Similarly, compatible power sources can offer extended battery life and reliable power supply, minimizing device-related interruptions. These compatible devices often come with advanced monitoring and data management capabilities. It enables real-time remote monitoring, allowing healthcare professionals to track patient status and more.

Heart Pump Device Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, The Heart Pump Device market is poised for significant growth in the coming years, driven by various factors and offering substantial future scope. The heart pump device market is poised for significant growth in the coming years, driven by factors such as the increasing prevalence of heart failure, technological advancements, and the growing adoption of minimally invasive and implantable devices. The largest segment in the market is Destination Therapy (DT), offering long-term mechanical circulatory support for patients ineligible for heart transplantation. On the other hand, the fastest-growing segment is Bridge-to-Recovery (BTR), which provides temporary support for patients with acute heart failure, aiming to facilitate cardiac recovery. In terms of regional dominance, North America holds the largest market share due to a high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and favorable reimbursement policies. Looking ahead, the future scope of the heart pump device market is promising, with ongoing advancements in technology, increasing research activities, and collaborations driving innovation. Furthermore, the growing demand for minimally invasive and implantable devices, along with expanding market opportunities in the Asia Pacific region, are expected to fuel market growth. As the heart pump device market continues to evolve, companies will focus on product development, strategic partnerships, and expanding their global footprint to capitalize on the growing demand and provide advanced solutions for patients with heart failure.

Report Metric Details
Market size value in 2023 USD 2.09 billion
Market size value in 2031 USD 15.32 billion
Growth Rate 24.77%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Ventricular assist devices (VADs), Intra-aortic balloon pumps (IABPs), Total artificial heart (TAH)
  • Indication
    • Bridge-to-transplant (BTT), Destination therapy (DT), Bridge-to-recovery (BTR)
  • End-user
    • Hospitals, cardiology centers, ambulatory surgical centers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories (US)
  • Medtronic PLC (Ireland)
  • LivaNova PLC (United Kingdom)
  • Berlin Heart GmbH (Germany)
  • SynCardia Systems, LLC (US)
  • Abiomed, Inc. (US)
  • Getinge AB (Sweden)
  • Terumo Corporation (Japan)
  • Teleflex Incorporated (US)
  • Jarvik Heart, Inc. (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Calon Cardio (United Kingdom)
  • CardiacAssist, Inc. (US)
  • BiVACOR Inc. (Australia)
  • Leviticus Cardio Ltd. (Israel)
  • CARMAT SA (France)
  • FineHeart SA (France)
  • MyLVAD (US)
  • MicroPort Scientific Corporation (China)
  • TandemLife, a LivaNova company (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Heart Pump Device Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Heart Pump Device Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Heart Pump Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Heart Pump Device Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Heart Pump Device Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Heart Pump Device Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Heart Pump Device Market size was valued at USD 2.09 billion in 2022 and is poised to grow from USD 2.61 billion in 2023 to USD 15.32 billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).

The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge. 'Abbott Laboratories (US)', 'Medtronic PLC (Ireland)', 'LivaNova PLC (United Kingdom)', 'Berlin Heart GmbH (Germany)', 'SynCardia Systems, LLC (US)', 'Abiomed, Inc. (US)', 'Getinge AB (Sweden)', 'Terumo Corporation (Japan)', 'Teleflex Incorporated (US)', 'Jarvik Heart, Inc. (US)', 'Fresenius Medical Care AG & Co. KGaA (Germany)', 'Calon Cardio (United Kingdom)', 'CardiacAssist, Inc. (US)', 'BiVACOR Inc. (Australia)', 'Leviticus Cardio Ltd. (Israel)', 'CARMAT SA (France)', 'FineHeart SA (France)', 'MyLVAD (US)', 'MicroPort Scientific Corporation (China)', 'TandemLife, a LivaNova company (US)'

Continuous innovation and advancements in heart pump technology have significantly improved the performance and outcomes of these devices. Technological advancements have led to the development of smaller, more durable, and more efficient heart pump devices, resulting in enhanced patient comfort and improved quality of life. For example, the introduction of magnetically levitated ventricular assist devices (LVADs) has reduced device-related complications and improved patient outcomes.

Availability of compatible devices: Compatible devices are designed to work harmoniously with heart pump systems, optimizing their performance and ensuring efficient functioning. For example, advanced control units can provide precise management of pump flow and parameters, enhancing patient outcomes. Similarly, compatible power sources can offer extended battery life and reliable power supply, minimizing device-related interruptions. These compatible devices often come with advanced monitoring and data management capabilities. It enables real-time remote monitoring, allowing healthcare professionals to track patient status and more.

North America holds the largest share in the heart pump device market. This can be attributed to several factors. Firstly, the region has a high prevalence of cardiovascular diseases, including heart failure, which drives the demand for heart pump devices. Additionally, North America has a well-established healthcare infrastructure and a high level of awareness about advanced medical technologies, contributing to the adoption of heart pump devices. The presence of key market players and ongoing research and development activities further support the growth of the market in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Heart Pump Device Market

Product ID: SQMIG35A2376

$5,300
BUY NOW GET FREE SAMPLE